. 2018 Feb 14;14(3):206-214.

doi: 10.1038/nchembio.2576.

How many human proteoforms are there?

Ruedi Aebersold¹, Jeffrey N Agar², I Jonathan Amster³, Mark S Baker⁴, Carolyn R Bertozzi⁵, Emily S Boja⁶, Catherine E Costello⁷, Benjamin F Cravatt⁸, Catherine Fenselau⁹, Benjamin A Garcia¹⁰, Ying Ge^{11

12}, Jeremy Gunawardena¹³, Ronald C Hendrickson¹⁴, Paul J Hergenrother¹⁵, Christian G Huber¹⁶, Alexander R Ivanov², Ole N Jensen¹⁷, Michael C Jewett¹⁸, Neil L Kelleher¹⁹, Laura L Kiessling²⁰, Nevan J Krogan²¹, Martin R Larsen¹⁷, Joseph A Loo²², Rachel R Ogorzalek Loo²², Emma Lundberg^{23

24}, Michael J MacCoss²⁵, Parag Mallick⁵, Vamsi K Mootha¹³, Milan Mrksich¹⁸, Tom W Muir²⁶, Steven M Patrie¹⁹, James J Pesavento²⁷, Sharon J Pitteri⁵, Henry Rodriguez⁶, Alan Saghatelian²⁸, Wendy Sandoval²⁹, Hartmut Schlüter³⁰, Salvatore Sechi³¹, Sarah A Slavoff³², Lloyd M Smith^{12

33}, Michael P Snyder²⁴, Paul M Thomas¹⁹, Mathias Uhlén³⁴, Jennifer E Van Eyk³⁵, Marc Vidal³⁶, David R Walt³⁷, Forest M White³⁸, Evan R Williams³⁹, Therese Wohlschlager¹⁶, Vicki H Wysocki⁴⁰, Nathan A Yates⁴¹, Nicolas L Young⁴², Bing Zhang⁴²

Affiliations

¹ Department of Biology, ETH Zurich, Zürich, Switzerland.
² Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
³ Department of Chemistry, University of Georgia, Athens, Georgia, USA.
⁴ Department of Biomedical Sciences, Macquarie University, Sydney, New South Wales, Australia.
⁵ Department of Chemistry, Stanford University, Stanford, California, USA.
⁶ Office of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, Maryland, USA.
⁷ Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, USA.
⁸ Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
⁹ Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, USA.
¹⁰ Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, and Epigenetics Institute, Philadelphia, Pennsylvania, USA.
¹¹ Department of Cell and Regenerative Biology, Human Proteomics Program, University of Wisconsin-Madison, Madison, Wisconsin, USA.
¹² Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
¹³ Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
¹⁴ Memorial Sloan Kettering Cancer Center, New York, New York, USA.
¹⁵ Department of Chemistry, University of Illinois, Urbana, Illinois, USA.
¹⁶ Department of Biosciences and Christian Doppler Laboratory for Biosimilar Characterization, University of Salzburg, Salzburg, Austria.
¹⁷ Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
¹⁸ The Center for Synthetic Biology, Northwestern University, Evanston, Illinois, USA.
¹⁹ Department of Chemistry, Molecular Biosciences and the Proteomics Center of Excellence, Northwestern University, Evanston, Illinois, USA.
²⁰ Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
²¹ Department of Cellular Molecular Pharmacology, University of California, San Francisco, California, USA.
²² Department of Biological Chemistry, University of California, Los Angeles, California, USA.
²³ Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.
²⁴ Department of Genetics, Stanford University, Stanford, California, USA.
²⁵ Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
²⁶ Department of Chemistry, Princeton University, Princeton, New Jersey, USA.
²⁷ Department of Biology, Saint Mary's College of California, Moraga, California, USA.
²⁸ Salk Institute for Biological Studies, Torrey Pines, California, USA.
²⁹ Applied Proteomics, Genentech, Inc., San Francisco, California, USA.
³⁰ Department of Clinical Chemistry/Central Laboratories, University Medical Center Hamburg - Eppendorf, Hamburg, Germany.
³¹ National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
³² Department of Chemistry, Yale University, New Haven, Connecticut, USA.
³³ Genome Center of Wisconsin, Madison, Wisconsin, USA.
³⁴ Department of Microbiology, KTH Royal Institute of Technology, Stockholm, Sweden.
³⁵ Cedars Sinai Medical Center, Los Angeles, California, USA.
³⁶ Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
³⁷ Department of Pathology, Harvard Medical School and Wyss Institute at Harvard University, Boston, Massachusetts, USA.
³⁸ Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
³⁹ Department of Chemistry, University of California, Berkeley, Berkeley, California, USA.
⁴⁰ Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio, USA.
⁴¹ Department of Cell Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
⁴² Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.

PMID: 29443976
PMCID: PMC5837046
DOI: 10.1038/nchembio.2576

How many human proteoforms are there?

Ruedi Aebersold et al. Nat Chem Biol. 2018.

. 2018 Feb 14;14(3):206-214.

doi: 10.1038/nchembio.2576.

Authors

Affiliations

¹ Department of Biology, ETH Zurich, Zürich, Switzerland.
² Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
³ Department of Chemistry, University of Georgia, Athens, Georgia, USA.
⁴ Department of Biomedical Sciences, Macquarie University, Sydney, New South Wales, Australia.
⁵ Department of Chemistry, Stanford University, Stanford, California, USA.
⁶ Office of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, Maryland, USA.
⁷ Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, USA.
⁸ Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, USA.
⁹ Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland, USA.
¹⁰ Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, and Epigenetics Institute, Philadelphia, Pennsylvania, USA.
¹¹ Department of Cell and Regenerative Biology, Human Proteomics Program, University of Wisconsin-Madison, Madison, Wisconsin, USA.
¹² Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
¹³ Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
¹⁴ Memorial Sloan Kettering Cancer Center, New York, New York, USA.
¹⁵ Department of Chemistry, University of Illinois, Urbana, Illinois, USA.
¹⁶ Department of Biosciences and Christian Doppler Laboratory for Biosimilar Characterization, University of Salzburg, Salzburg, Austria.
¹⁷ Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
¹⁸ The Center for Synthetic Biology, Northwestern University, Evanston, Illinois, USA.
¹⁹ Department of Chemistry, Molecular Biosciences and the Proteomics Center of Excellence, Northwestern University, Evanston, Illinois, USA.
²⁰ Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
²¹ Department of Cellular Molecular Pharmacology, University of California, San Francisco, California, USA.
²² Department of Biological Chemistry, University of California, Los Angeles, California, USA.
²³ Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.
²⁴ Department of Genetics, Stanford University, Stanford, California, USA.
²⁵ Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
²⁶ Department of Chemistry, Princeton University, Princeton, New Jersey, USA.
²⁷ Department of Biology, Saint Mary's College of California, Moraga, California, USA.
²⁸ Salk Institute for Biological Studies, Torrey Pines, California, USA.
²⁹ Applied Proteomics, Genentech, Inc., San Francisco, California, USA.
³⁰ Department of Clinical Chemistry/Central Laboratories, University Medical Center Hamburg - Eppendorf, Hamburg, Germany.
³¹ National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA.
³² Department of Chemistry, Yale University, New Haven, Connecticut, USA.
³³ Genome Center of Wisconsin, Madison, Wisconsin, USA.
³⁴ Department of Microbiology, KTH Royal Institute of Technology, Stockholm, Sweden.
³⁵ Cedars Sinai Medical Center, Los Angeles, California, USA.
³⁶ Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
³⁷ Department of Pathology, Harvard Medical School and Wyss Institute at Harvard University, Boston, Massachusetts, USA.
³⁸ Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
³⁹ Department of Chemistry, University of California, Berkeley, Berkeley, California, USA.
⁴⁰ Department of Chemistry and Biochemistry, The Ohio State University, Columbus, Ohio, USA.
⁴¹ Department of Cell Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
⁴² Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.

PMID: 29443976
PMCID: PMC5837046
DOI: 10.1038/nchembio.2576

Abstract

Despite decades of accumulated knowledge about proteins and their post-translational modifications (PTMs), numerous questions remain regarding their molecular composition and biological function. One of the most fundamental queries is the extent to which the combinations of DNA-, RNA- and PTM-level variations explode the complexity of the human proteome. Here, we outline what we know from current databases and measurement strategies including mass spectrometry-based proteomics. In doing so, we examine prevailing notions about the number of modifications displayed on human proteins and how they combine to generate the protein diversity underlying health and disease. We frame central issues regarding determination of protein-level variation and PTMs, including some paradoxes present in the field today. We use this framework to assess existing data and to ask the question, "How many distinct primary structures of proteins (proteoforms) are created from the 20,300 human genes?" We also explore prospects for improving measurements to better regularize protein-level biology and efficiently associate PTMs to function and phenotype.

PubMed Disclaimer

Conflict of interest statement

Competing financial interests

The authors declare no competing financial interests.

Figures

**Figure 1. Two parsings of post-translational modifications from the SwissProt database of 20,245 human proteins**
(a) Histogram of PTMs in SwissProt for *Homo sapiens* (taxon identifier: 9606). Phosphorylation (phospho) is by far the most frequently annotated PTM at 38,030 (72%). Note that there are ~400 different types of PTMs known in biology (see: http://www.unimod.org). (b) Histogram of PTMs per SwissProt entry. Note that the distribution of PTMs is not uniform with 75% of entries containing two or fewer annotated PTMs; yet only five entries have >90 annotated PTMs.

**Figure 2. Graphical depiction of sources of protein variation that combine to make up proteoforms, each of which map back to a single human gene**
Depicted is a single human gene and two of its isoforms, which differ by the coding for several different amino acids of a protein primary sequence (at left); isoforms commonly arise from alternative splicing of RNA and from use of different promoters or translational start sites. Isoform variation combines with site-specific changes to generate human proteoforms (at right); three examples of site-specific changes include single-nucleotide polymorphisms (SNPs) and co- or post-translational modifications like N-glycosylation or phosphorylation, respectively.

**Figure 3. Contrasting the potential sources of protein variability versus those that actually occur in combination as proteoforms detectable in actual human systems**
(a) Common sources of protein variability include alternative splicing of RNA, single-nucleotide polymorphisms (SNPs) in regions of genes coding for amino acids, and PTMs. Note that there are ~33,000 splice isoforms, ~78,000 site-specific amino acid variants (i.e., polymorphisms and mutations) and ~53,000 PTMs in the October 2017 release of the Human SwissProt database. (b) Depiction of two proteoforms from specific combinations of protein variability.

**Figure 4. Levels of organization in the human body**
Starting from protein primary structure (proteoforms), the complexity of organ systems is built up in layers. A key concept is that diverse measurement approaches in proteomics seeks analysis of protein molecules at the various levels and contexts represented. Proteoform membership in protein complexes and localization within organelles, cells and tissues are all aspirations of measurement technologies to map protein molecules more precisely in molecular composition, across space and through time.

**Figure 5. Proteoforms and their families underlie complex traits and molecular mechanisms operative in living systems**
In nature, individual proteoforms (left), arising from variable sources of biological variation like PTMs, often exist in groups of related proteoforms. These dynamic ‘proteoform families’ (middle left) are the true protein products from the same human gene that convey information within signaling and regulatory networks (middle right) that underlie complex traits in wellness and disease (right). Discrete proteoforms and their families offer challenging, high-value targets for direct measurement by top-down proteomics.

See this image and copyright information in PMC

References

1. Gaudet P, et al. The neXtProt knowledgebase on human proteins: 2017 update. Nucleic Acids Res. 2017;45:D177–D182. - PMC - PubMed
1. Uhlén M, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419. - PubMed
1. Aken BL, et al. Ensembl 2017. Nucleic Acids Res. 2017;45:D635–D642. - PMC - PubMed
1. The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2017;45:D158–D169. This manuscript introduces UniProt, a centralized, authoritative resource for protein sequences. - PMC - PubMed
1. Duek P, Bairoch A, Gateau A, Vandenbrouck Y, Lane L. Missing protein landscape of human chromosomes 2 and 14: progress and current status. J. Proteome Res. 2016;15:3971–3978. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

How many human proteoforms are there?

Affiliations

How many human proteoforms are there?

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous